STAAR Surgical Co (STAA) Return on equity 2018–2025
STAAR Surgical Co (STAA) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-23.4%FY2025 · since FY2018: 3.8% → -23.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -23.4% | -18.3 pp |
| FY2024 | -5.1% | -10.6 pp |
| FY2023 | 5.5% | -6.3 pp |
| FY2022 | 11.8% | +1.3 pp |
| FY2021 | 10.5% | +7.5 pp |
| FY2020 | 3.0% | -5.8 pp |
| FY2019 | 8.8% | +5.0 pp |
| FY2018 | 3.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More STAA financial trends
STAA RevenueSTAA Net incomeSTAA Net marginSTAA Gross profitSTAA Gross marginSTAA Operating incomeSTAA Operating marginSTAA Operating cash flowSTAA Free cash flowSTAA Capital expendituresSTAA Stock buybacksSTAA Dividends paidSTAA Total assetsSTAA Total liabilitiesSTAA Shareholders’ equitySTAA overview →